RE:RE:RE:RE:Weird Thinggebremeskel wrote: It's very difficult to understand why they didn't do it the way you suggest. What was their rationale? Were they intentionally keeping the stock price down to accommodate certain investors?
Bunge wrote:
Simple.
NEVER release prospectus (hold off 2 months) night before AGM and we were at 55 cents.
GET the hype from the AGM.
THEN release the following (which were in the holster):
1. Regulatory Updates from Health Canada and US FDA
2. Theralase Releases 2019 Annual General Meeting Video Presentations
3. Theralase Receives Notice of Acceptance for Multiwavelength Photo Dynamic Therapy from Russian Patent Office
4. Theralase Signs Agreement with Urology Organization to Provide US Clinical Study Sites for its Phase II Non Muscle Invasive Bladder Cancer Clinical Study
5. Theralase Enrolls First Patient into Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
6. McGill University Health Centre Newest Clinical Study Site for Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
7. Patient Five Cancer-Free Eighteen Months After Single Anti-Cancer Treatment
SEE what those developments would have brought organically to the share price?
They couldn't have waited 60 days for a PP to be announced (with terms)?
They wiped out half our market cap.
I would call that incompetent.
It's probably incompetent prostitutes management style plus the conspiracy to screw the long shareholders like us.... Anyway, in science we trust....